 Carbamazepine maintenance treatment outpatient schizophrenics double-blind crossover trial carbamazepine sole maintenance treatment chronic nonmanic schizophrenic outpatients conditions use neuroleptics prior Criteria treatment effectiveness number patients time neuroleptic-free period carbamazepine placebo Relapse concordance psychiatric ratings independent clinical judgements significant worsening Results patients carbamazepine placebo first phase treatment comparison descriptive findings second phase available patients evidence existence treatment-relevant subgroup episodic dyscontrol phenomena